🇺🇸 NX in United States

123 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 123

Most-reported reactions

1. Confusional State — 16 reports (13.01%)
2. Nausea — 14 reports (11.38%)
3. Anxiety — 13 reports (10.57%)
4. Depression — 13 reports (10.57%)
5. Abnormal Dreams — 12 reports (9.76%)
6. Hallucination — 12 reports (9.76%)
7. Amnesia — 11 reports (8.94%)
8. Drug Hypersensitivity — 11 reports (8.94%)
9. Nervousness — 11 reports (8.94%)
10. Visual Disturbance — 10 reports (8.13%)

Source database →

Frequently asked questions

Is NX approved in United States?

NX does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for NX in United States?

GBG Forschungs GmbH is the originator. The local marketing authorisation holder may differ — check the official source linked above.